Nasal Drug Delivery Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Nasal Drug Delivery Market Analysis
The nasal drug delivery market will show a rapid growth owing to the increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy, growing adoption of self-administration practices and the rise in demand for home healthcare devices.
The nasal drug delivery is found to be one of the most preferred drug delivery routes among patients as well as healthcare providers and this can be majorly attributed to the non-invasive nature of the drug delivery and higher drug absorbability through the nasal route. In addition, the nasal route provides a less hostile environment as compared to the other routes and this allows better absorption of drugs.
Moreover, nasal drug delivery does not require any sterile method for administering drugs into the body. Therefore the easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which in turn drives the patient outcomes. Moreover, the rising patient preference for nasal products owing to increased awareness along with their efficacy and easy administration properties is anticipated to fuel the market growth.
Nasal Drug Delivery Market Trends
This section covers the major market trends shaping the Nasal Drug Delivery Market according to our research experts:
Drops and Liquids is Expected to be the Fastest Growing Segment During the Forecast Period
Drops and liquids segment is estimated to be the fastest-growing dosage form segment with a high CAGR and its growth can be attributed to the affordability and treatment success rates of these liquid products. As there has also been a rising demand for self-administration and increasing patient compliance that is also likely to augment the market growth.
In addition, the availability of various nasal drops and liquids products in the market is expected to contribute to the segment growth over the coming years.
North America is Anticipated to Dominate the Nasal Drug Delivery Market
The North America region dominates the nasal drug delivery technology market due to the advanced technology, products launches and innovation, growing prevalence of asthma and chronic obstructive pulmonary disease and increasing adoption of early treatment procedures. As the chronic obstructive pulmonary disease is found to be the third leading cause of death in the United States, therefore the increasing prevalence of COPD may help in increasing the adoption of nasal drug delivery devices. There are also an the increasing number of individuals with asthma that helps to witness strong growth over the forecast period.
Asia Pacific is also expected to witness the fastest CAGR due to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.
Nasal Drug Delivery Industry Overview
The market is likely to face intense competition over the forecast period owing to the presence of many multinational companies. Geographical expansion, new product development, and joint ventures are some of the key strategies undertaken by key market players. For instance, in 2017, Merck collaborated with Premier, Inc. (US) to develop a preventive care model that seeks to improve adolescent and adult vaccination rates.
Nasal Drug Delivery Market Leaders
-
Neurelis, Inc.
-
Aptargroup, Inc.
-
Becton, Dickinson and Company
-
Astrazeneca PLC
-
3M Company
*Disclaimer: Major Players sorted in no particular order
Nasal Drug Delivery Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Patient Preference for Nasal Drug Delivery as A Result of Easy Administration and Better Efficacy
- 4.2.2 Growing Adoption of Self-Administration Practices
- 4.2.3 Rise in Demand for Home Healthcare Devices
-
4.3 Market Restraints
- 4.3.1 Complications Associated With the Overuse of Nasal Sprays
- 4.3.2 Patent Expiry of Several Drugs
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Dosage Form
- 5.1.1 Sprays
- 5.1.2 Drops and Liquids
- 5.1.3 Gels
- 5.1.4 Others
-
5.2 By Containers
- 5.2.1 Non-Pressurized Containers
- 5.2.2 Pressurized Containers
-
5.3 By Therapeutic Application
- 5.3.1 Rhinitis
- 5.3.2 Nasal Congestion
- 5.3.3 Asthma
- 5.3.4 Others
-
5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Home Health Care
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3M Company
- 6.1.2 Neurelis, Inc.
- 6.1.3 Aptargroup, Inc.
- 6.1.4 Astrazeneca PLC
- 6.1.5 Becton, Dickinson and Company
- 6.1.6 Glaxosmithkline PLC
- 6.1.7 Johnson & Johnson Services, Inc.
- 6.1.8 Merck & Co., Inc.
- 6.1.9 Novartis AG
- 6.1.10 Pfizer Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNasal Drug Delivery Industry Segmentation
As per the scope of the report, nasal drug delivery is the administration of the drug through the nasal route. Nasal route of administration provides direct access to the systemic circulation. The nasal drug delivery is used as a treatment of local infection in the nasal course & paranasal sinuses such as rhinitis. This technique is used to lessen the problem of slow absorption of drugs, degradation before reaching the target site, and poor bioavailability.
| By Dosage Form | Sprays | |
| Drops and Liquids | ||
| Gels | ||
| Others | ||
| By Containers | Non-Pressurized Containers | |
| Pressurized Containers | ||
| By Therapeutic Application | Rhinitis | |
| Nasal Congestion | ||
| Asthma | ||
| Others | ||
| By End User | Hospitals | |
| Home Health Care | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Nasal Drug Delivery Market Research FAQs
What is the current Nasal Drug Delivery Market size?
The Nasal Drug Delivery Market is projected to register a CAGR of 6.30% during the forecast period (2024-2029)
Who are the key players in Nasal Drug Delivery Market?
Neurelis, Inc., Aptargroup, Inc., Becton, Dickinson and Company, Astrazeneca PLC and 3M Company are the major companies operating in the Nasal Drug Delivery Market.
Which is the fastest growing region in Nasal Drug Delivery Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Nasal Drug Delivery Market?
In 2024, the North America accounts for the largest market share in Nasal Drug Delivery Market.
What years does this Nasal Drug Delivery Market cover?
The report covers the Nasal Drug Delivery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nasal Drug Delivery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Nasal Drug Delivery Industry Report
Statistics for the 2024 Nasal Drug Delivery market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Nasal Drug Delivery analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
